Lv11
40 积分 2023-08-21 加入
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
3小时前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
3小时前
待确认
Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features
9天前
已完结
Bacteriophage-derived depolymerase: a review on prospective antibacterial agents to combat Klebsiella pneumoniae
6个月前
已完结
Klebsiella pneumoniae: adaptive immune landscapes and vaccine horizons
8个月前
已完结
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae
8个月前
已完结
皖公网安备34019202002308
